Citi analyst Chasen Bender maintained a Buy rating on Herbalife today and set a price target of $11.00.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Chasen Bender has given his Buy rating due to a combination of factors that indicate potential upside for Herbalife’s stock. Despite some mixed signals in web and app traffic data, there are signs of improvement in certain markets. For instance, while global traffic to myherbalife.com showed a year-over-year decline, the sequential trends suggest a gradual recovery. In the U.S., although total visits worsened, the average unique visitors trend improved month-over-month, indicating a potential stabilization.
Furthermore, Bender’s short-term view anticipates a 14.5% expected share price return, which supports a positive outlook for the stock. While traffic in markets like Mexico and India showed declines, the overall expected earnings per share and the potential for recovery in key regions contribute to the Buy recommendation. These elements combined suggest that Herbalife may offer a favorable investment opportunity despite current challenges.
In another report released on August 7, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $10.00 price target.